4.8 Review

Enantioselective C(sp(3))-H bond activation by chiral transition metal catalysts

Journal

SCIENCE
Volume 359, Issue 6377, Pages 759-+

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.aao4798

Keywords

-

Funding

  1. Scripps Research Institute (TSRI)
  2. NIH (National Institute of General Medical Sciences) [2R01GM084019]
  3. Bristol-Myers Squibb
  4. NSF under the Centers for Chemical Innovation Center for Selective C-H Functionalization [CHE-1205646]
  5. NSF
  6. TSRI
  7. Boehringer Ingelheim
  8. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084019] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Organic molecules are rich in carbon-hydrogen bonds; consequently, the transformation of C-H bonds to new functionalities (such as C-C, C-N, and C-O bonds) has garnered much attention by the synthetic chemistry community. The utility of C-H activation in organic synthesis, however, cannot be fully realized until chemists achieve stereocontrol in the modification of C-H bonds. This Review highlights recent efforts to enantioselectively functionalize C(sp(3))-H bonds via transition metal catalysis, with an emphasis on key principles for both the development of chiral ligand scaffolds that can accelerate metalation of C(sp(3))-H bonds and stereomodels for asymmetric metalation of prochiral C-H bonds by these catalysts.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available